Skip to main content
Clinical Trials/NCT00738036
NCT00738036
Completed
Not Applicable

Acute Pain Episodes in Patients Under Opioid Maintenance Therapy : Clinical Management and Long Term Effects

University Hospital, Toulouse1 site in 1 country151 target enrollmentApril 2008
ConditionsAcute Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Pain
Sponsor
University Hospital, Toulouse
Enrollment
151
Locations
1
Primary Endpoint
Retention rate under buprenorphine or methadone treatment defined as the percentage of patients still under treatment during the follow-up
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

To define a rational pharmacological management of pain for the subjects under opioid maintenance therapy (methadone or buprenorphine), it is first of all necessary to estimate the efficiency of the current practices on pain management as well as their potentially noxious consequences, in particular on the long term opioid maintenance therapy.

The objective of the study is to compare the efficiency of the opioid maintenance therapy according to the arisen of an acute painful phenomenon requiring an analgesic management for these patients. At first, this work will allow to determine the results on acute pain of the current practices for these patients. The comparison of the long term consequences on opioid maintenance therapy between the patients that presented an acute painful phenomenon and the control patients should help to improve acute pain management for these patients while limiting the risk of relapse in the abused consumption of psychoactive substances.

Registry
clinicaltrials.gov
Start Date
April 2008
End Date
November 2009
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18 or more.
  • Patients under opioid maintenance therapy (buprenorphine or methadone)
  • Patients treated by the same drug (buprenorphine or methadone) since at least 3 months

Exclusion Criteria

  • Refusal of the patient to take part in the study
  • Absence of possible follow-up

Outcomes

Primary Outcomes

Retention rate under buprenorphine or methadone treatment defined as the percentage of patients still under treatment during the follow-up

Time Frame: 1, 3, 6 and 12 months

Secondary Outcomes

  • pain, anxiety, drugs, alcohol and other substances abuse and dependence, drug prescription (included for pain treatment and opioid maintenance)(1, 3, 6 and 12 months)

Study Sites (1)

Loading locations...

Similar Trials